cTnI/Mb/CK-MB三项检测板快速诊断急性心肌梗死的临床价值  

Clinical Value of Rapid Diagnosis with Troponin I/Myoglobin/CK-MB One Step Combo Device in Patients with Acute Myocardial Infarction

作　　者：葛文亮[1] 

机构地区：[1]江苏省无锡市第二人民医院检验科,无锡214002

出　　处：《中国医药导刊》2009年第11期1840-1841,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨cTnI/Mb/CK-MB三项检测板对AMI的快速诊断价值。方法:在cTnI/Mb/CK-MB三项检测板上同时定性检测89例疑为AMI患者的肌钙蛋白I(cTnI)、肌红蛋白(Mb)、肌酸激酶同功酶(CK-MB)。结果:cTnI、Mb和CK-MB对AMI的敏感性分别为93.1%,96.6%,89.7%,特异性分别为96.8%,45.2%,58.1%;cTnI、Mb、CK-MB联检对AMI的敏感性达89.7%,而综合特异性达100%。结论:cTnI/Mb/CK-MB三项检测板操作简便,快捷,对AMI的快速诊断具有较好的临床应用价值。Objective：To explore the value of rapid diagnosis with Troponin I/Myoglobin/CK-MB One Step Combo Device in Pationts with acute myocardial infarction.Metbods：Plasma cTnI.Mb and CK-MB were qualitativly determined with Troponin I/Myoglobin/CK-MB One Step Combo Device in 89 patients probably with acute myocardial infarction.Results：The sensitivity of cTnI in patients with acute myocardial infarction was 93.1%. specificiry 96.8%,Mb was 96.6%and 45.2%,CK-MB was 89.7% and 58.1%.The sensitivity of combined detection of cTnI.Mb and CK-MB reached 89.7% while the synthetic specificity 100%.Conclusions：Troponin I/Myoglobin/CK-MB One Step Combo Device is vaual in rapid diagnosis of patients with acute myocardial infarction.

关 键 词：肌钙蛋白I 肌红蛋白 肌酸激酵同功酶 急性心肌梗死 

分 类 号：R542.22[医药卫生—心血管疾病]